1 2-dihydroquinolyl))he xa-1,3,5-trienyl]amino]aminomethane-1-thione (10) exhibited activity at 5.0-10.

2 re suspended in a dilute tris(hydroxymethyl)-aminomethane/2-(N-morpholino) ethanesulfonic acid buffer

3 oxy-4,5-dihydro-3H-naphtho[1,8-bc]furan-5-yl)aminomethane, 6b, had K(i) values for displacement of [(

4 increasing plasma sodium, tris-hydroxymethyl aminomethane acts by increasing plasma weak base concent

5  to 1 mM, using the bases tris(hydroxymethyl)aminomethane, ammonia, carbonate, hydroxide, hydrogen ph

6  Tris-acetate-EDTA; Tris, tris[hydroxymethyl]aminomethane) buffer.

7 rm at 2.4 A resolution; a tris(hydroxymethyl)aminomethane-Co(II)-enzyme complex structure at 1.8 A re

8 roxide oxidation of Tris [tris(hydroxymethyl)aminomethane] present in transcription buffer and spermi

9                           Tris-hydroxymethyl aminomethane (THAM) may be an effective method to contro

10 ased on pyridine (py) and tris(hydroxymethyl)aminomethane (TRIS) are catalytically inactive.

11     The organic compounds tris(hydroxymethyl)aminomethane (Tris), urea, dithiothreitol (DTT), glycero

12 sphate in the presence of tris(hydroxymethyl)aminomethane (Tris).

13 r of N-formylglycine with Tris(hydroxymethyl)aminomethane, with the rate of peptidyl transfer by the